Takeda logo

Investor Events and Presentations | Takeda Pharmaceuticals

IR calendar

Company Events & Broker Conferences FY2022 (April 2022-March 2023)

TAK-279 (TYK2 inhibitor) Investor Call on Phase 2b Psoriasis Data

(March 18, 2023)

QDENGA Investor call

(March 15, 2023)

Cowen 43rd Health Care Conference

(March 6, 2023)

41st Annual J.P. Morgan Healthcare Conference

(January 9, 2023)

Conference call regarding acquisition of NDI-034858 From Nimbus Therapeutics

(December 13, 2022)

Jefferies London Healthcare Conference

(November 15, 2022)

  • This event was closed.

Seminar: Investors and Analysts on Lysosomal Storage Diseases (LSD)

(October 4, 2022)

Morgan Stanley Healthcare Conference

(September 12, 2022)

Jefferies Healthcare Conference

(June 9, 2022)

  • This event was closed.

Past events

Annual Shareholder meetings

146th Ordinary General Meeting of Shareholders

(June 29, 2022)

Past Shareholder events

Retail Investor Event

February 22, 2023

Sign up for our investors newsletter

Stay up to date on financial results, corporate milestones and learn how we're delivering on our commitment to patients, our people and the planet

Sign up